The correlation of axillary ultrasonography with histologic breast cancer downstaging after induction chemotherapy

被引:42
作者
Vlastos, G
Fornage, BD
Mirza, NQ
Bedi, D
Lenert, JT
Winchester, DJ
Tolley, SM
Ames, FC
Ross, MI
Feig, BW
Hunt, KK
Buzdar, AU
Singletary, SE
机构
[1] Univ Texas, MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA
[2] Univ Texas, MD Anderson Canc Ctr, Dept Diagnost Imaging, Houston, TX 77030 USA
[3] Univ Texas, MD Anderson Canc Ctr, Dept Med Breast Oncol, Houston, TX 77030 USA
[4] Northwestern Univ, Evanston Hosp, Evanston, IL 60201 USA
关键词
D O I
10.1016/S0002-9610(00)00382-2
中图分类号
R61 [外科手术学];
学科分类号
摘要
BACKGROUND: The goal of this study was to examine the role of ultrasonography in detecting axillary lymph node metastases in stage II breast cancer patients after induction chemotherapy (IC). METHODS: Of 172 consecutive patients with T1-3, N0-1, MO breast cancer registered in a prospective IC trial, a subset of 130 evaluable patients were chosen, with (1) both physical and ultrasonographic examinations of the axilla before and after IC; (2) exactly four cycles of IC; (3) no presurgical radiation therapy; and (4) an axillary lymph node dissection. RESULTS: Before IC, 32 patients (25%) were negative for axillary involvement by both physical and ultrasonographic examinations. After IC, this number increased to 64 (49%). Of these, 31 (48%) were positive by pathology examination. In most cases, however, the residual tumor was minimal. CONCLUSIONS: Stage II breast cancer patients who were or became node negative by both ultrasonographic and physical examinations after IC had a 48% incidence of nodal metastases. Because the residual tumor was minimal, irradiation may be sufficient for adequate local control of the axilla. (C) 2000 by Excerpta Medica, Inc.
引用
收藏
页码:446 / 452
页数:7
相关论文
共 51 条
[1]  
ABE O, 1995, NEW ENGL J MED, V333, P1444
[2]   Lymphatic mapping and sentinel node biopsy in the patient with breast cancer [J].
Albertini, JJ ;
Lyman, GH ;
Cox, C ;
Yeatman, T ;
Balducci, L ;
Ku, NN ;
Shivers, S ;
Berman, C ;
Wells, K ;
Rapaport, D ;
Shons, A ;
Horton, J ;
Greenberg, H ;
Nicosia, S ;
Clark, R ;
Cantor, A ;
Reintgen, DS .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (22) :1818-1822
[3]   Assessment of axillary lymph node involvement in breast cancer patients with positron emission tomography using radiolabeled 2-(fluorine-18)fluoro-2-deoxy-D-glucose [J].
Avril, N ;
Dose, J ;
Janicke, F ;
Ziegler, S ;
Romer, W ;
Weber, W ;
Herz, M ;
Nathrath, W ;
Graeff, H ;
Schwaiger, M .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (17) :1204-1209
[4]   Ultrasound-guided aspiration biopsy for detection of nonpalpable axillary node metastases in breast cancer patients: New diagnostic method [J].
Bonnema, J ;
vanGeel, AN ;
vanOoijen, B ;
Mali, SPM ;
Tjiam, SL ;
HenzenLogmans, SC ;
Schmitz, PIM ;
Wiggers, T .
WORLD JOURNAL OF SURGERY, 1997, 21 (03) :270-274
[5]   POSTOPERATIVE AXILLARY LYMPHOSCINTIGRAPHY IN THE MANAGEMENT OF BREAST-CANCER [J].
BOURGEOIS, P ;
FRUHLING, J ;
HENRY, J .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1983, 9 (01) :29-32
[6]  
BRUCE J, 1971, CANCER, V18, P1443
[7]   AXILLARY LYMPH-NODE METASTASES IN BREAST-CANCER - PREOPERATIVE DETECTION WITH US [J].
BRUNETON, JN ;
CARAMELLA, E ;
HERY, M ;
AUBANEL, D ;
MANZINO, JJ ;
PICARD, JL .
RADIOLOGY, 1986, 158 (02) :325-326
[8]   Prospective evaluation of paclitaxel versus combination chemotherapy with fluorouracil, doxorubicin, and cyclophosphamide as neoadjuvant therapy in patients with operable breast cancer [J].
Buzdar, AU ;
Singletary, SE ;
Theriault, RL ;
Booser, DJ ;
Valero, V ;
Ibrahim, N ;
Smith, TL ;
Asmar, L ;
Frye, D ;
Manuel, N ;
Kau, SW ;
McNeese, M ;
Strom, E ;
Hunt, K ;
Ames, F ;
Hortobagyi, GN .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (11) :3412-3417
[9]  
Cady B, 1996, ARCH SURG-CHICAGO, V131, P301
[10]  
CALLE R, 1978, CANCER-AM CANCER SOC, V42, P2045, DOI 10.1002/1097-0142(197810)42:4<2045::AID-CNCR2820420455>3.0.CO